{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:56:58Z","timestamp":1791655018433,"version":"4.3.4"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.addr.2023.115144","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:57:29Z","timestamp":1700625449000},"page":"115144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano\u2013bio interactions"],"prefix":"10.1016","volume":"203","author":[{"given":"Mengjun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangkun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Cun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3201-4696","authenticated-orcid":false,"given":"Mingshi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2023.115144_b0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1513\/AnnalsATS.201311-405PS","article-title":"The global burden of respiratory disease","volume":"11","author":"Ferkol","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.addr.2023.115144_b0010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jsps.2021.10.008","article-title":"Current views in chronic obstructive pulmonary disease pathogenesis and management","volume":"29","author":"Alfahad","year":"2021","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.addr.2023.115144_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/pharmaceutics13020177","article-title":"Inhaled RNA therapeutics for obstructive airway diseases: Recent advances and future prospects","volume":"13","author":"Xu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.115144_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.addr.2018.04.010","article-title":"Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases","volume":"133","author":"Newman","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tips.2020.08.004","article-title":"Paving the road for RNA therapeutics","volume":"41","author":"Dammes","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/ph6020223","article-title":"RNAi therapeutic platforms for lung diseases","volume":"6","author":"Fujita","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.addr.2023.115144_b0035","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.matt.2020.09.020","article-title":"Nanomaterials for therapeutic RNA delivery","volume":"3","author":"Han","year":"2020","journal-title":"Matter"},{"key":"10.1016\/j.addr.2023.115144_b0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12931-022-02069-8","article-title":"Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease","volume":"23","author":"Liu","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.addr.2023.115144_b0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2020.08.002","article-title":"Inhaled RNA therapy: From promise to reality","volume":"41","author":"Chow","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jconrel.2020.11.005","article-title":"Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges","volume":"330","author":"Ding","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41587-020-0692-z","article-title":"Mist begins to clear for lung delivery of RNA","volume":"38","author":"Shaffer","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2023.115144_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejpb.2019.09.020","article-title":"The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles","volume":"144","author":"Garcia-Mouton","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2023.115144_b0065","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/acsnano.7b01873","article-title":"Unveiling the molecular structure of pulmonary surfactant corona on nanoparticles","volume":"11","author":"Hu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115144_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114577","article-title":"Cell-specific drug targeting in the lung","volume":"190","author":"Abed","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2023.115144_b0075","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.2174\/1381612826999201116161143","article-title":"Advancing of cellular signaling pathways in respiratory diseases using nanocarrier based drug delivery systems","volume":"26","author":"Mehta","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2023.115144_b0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009589","article-title":"CFTR, mucins, and mucus obstruction in cystic fibrosis","volume":"2","author":"Kreda","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2023.115144_b0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2008.09.010","article-title":"Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy","volume":"61","author":"Griesenbach","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0090","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.ymthe.2018.05.014","article-title":"Lipid nanoparticle-delivered chemically modified mRNA restores chloride secretion in cystic fibrosis","volume":"26","author":"Robinson","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2023.115144_b0095","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cell.2013.08.045","article-title":"High-content siRNA screen reveals global ENaC regulators and potential cystic fibrosis therapy targets","volume":"154","author":"Alma\u00e7a","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.addr.2023.115144_b0100","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jcf.2019.12.012","article-title":"New approaches to genetic therapies for cystic fibrosis","volume":"19","author":"Christopher Boyd","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.addr.2023.115144_b0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thoraxjnl-2017-210670","article-title":"Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung","volume":"73","author":"Tagalakis","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.addr.2023.115144_b0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcf.2017.05.003","article-title":"Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice","volume":"16","author":"Crosby","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.addr.2023.115144_b0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMra003200","article-title":"Idiopathic pulmonary fibrosis","volume":"345","author":"Gross","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2023.115144_b0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2023.115144_b0125","first-page":"1765","article-title":"Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis, Nanomedicine: Nanotechnology","volume":"14","author":"Ding","year":"2018","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.addr.2023.115144_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2019.10.030","article-title":"Treatment of acute lung injury and early-and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes","volume":"314","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fphar.2019.00074","article-title":"Challenges facing airway epithelial cell-based therapy for cystic fibrosis","volume":"10","author":"Berical","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2023.115144_b0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/ijms21020524","article-title":"Idiopathic pulmonary fibrosis: Pathogenesis and the emerging role of long non-coding RNAs","volume":"21","author":"Hadjicharalambous","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0145","article-title":"Chronic mucus hypersecretion in severe asthma","author":"Wedge","year":"2017","journal-title":"Eur Respiratory Soc"},{"key":"10.1016\/j.addr.2023.115144_b0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.coi.2019.07.010","article-title":"Interactions between environmental pollutants and genetic susceptibility in asthma risk","volume":"60","author":"Johansson","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0155","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"G.I.f.A. program, the global burden of asthma: executive summary of the GINA dissemination committee report","volume":"59","author":"Masoli","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.addr.2023.115144_b0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2023.115144_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.983852","article-title":"Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives","volume":"13","author":"Kardas","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0175","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.addr.2023.115144_b0180","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ddr.21571","article-title":"The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress","volume":"80","author":"Dua","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.addr.2023.115144_b0185","first-page":"1","article-title":"Targeting cell signaling in allergic asthma, signal transduction and targeted","volume":"4","author":"Athari","year":"2019","journal-title":"Therapy"},{"key":"10.1016\/j.addr.2023.115144_b0190","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/crj.13407","article-title":"Mechanisms and biomarkers of airway epithelial cell damage in asthma: A review","volume":"15","author":"Yang","year":"2021","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.addr.2023.115144_b0195","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/all.14421","article-title":"Epithelial cell dysfunction, a major driver of asthma development","volume":"75","author":"Heijink","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.addr.2023.115144_b0200","doi-asserted-by":"crossref","first-page":"L500","DOI":"10.1152\/ajplung.00237.2019","article-title":"Airway epithelial-targeted nanoparticles for asthma therapy","volume":"318","author":"Kan","year":"2020","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.addr.2023.115144_b0205","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.3390\/ijms22179112","article-title":"Nerve growth factor: A potential therapeutic target for lung diseases","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0210","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2222.2011.03918.x","article-title":"Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA","volume":"42","author":"Ogawa","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.addr.2023.115144_b0215","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/mtna.2014.11","article-title":"Small interfering RNA targeting nerve growth factor alleviates allergic airway hyperresponsiveness","volume":"3","author":"Chen","year":"2014","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"10.1016\/j.addr.2023.115144_b0220","doi-asserted-by":"crossref","first-page":"e25301","DOI":"10.4161\/jkst.25301","article-title":"STAT6 and lung inflammation","volume":"2","author":"Walford","year":"2013","journal-title":"Jak-Stat"},{"key":"10.1016\/j.addr.2023.115144_b0225","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.humimm.2014.06.007","article-title":"Association of STAT6 variants with asthma risk: a systematic review and meta-analysis","volume":"75","author":"Qian","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0230","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaci.2004.10.006","article-title":"Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes","volume":"115","author":"Pyk\u00e4l\u00e4inen","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0235","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1067\/mai.2001.119554","article-title":"Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium","volume":"108","author":"Mullings","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0240","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/intimm\/dxh151","article-title":"STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation","volume":"16","author":"Hoshino","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0245","doi-asserted-by":"crossref","first-page":"e90338","DOI":"10.1371\/journal.pone.0090338","article-title":"Development of pre-clinical models for evaluating the therapeutic potential of candidate siRNA targeting STAT6","volume":"9","author":"Healey","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2023.115144_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7835284","article-title":"The role of T cells and macrophages in asthma pathogenesis: a new perspective on mutual crosstalk","volume":"2020","author":"Zhu","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.addr.2023.115144_b0255","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nri2870","article-title":"Functions of T cells in asthma: more than just TH2 cells","volume":"10","author":"Lloyd","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0260","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","article-title":"Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa","volume":"201","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0265","doi-asserted-by":"crossref","first-page":"337ra365","DOI":"10.1126\/scitranslmed.aaf1938","article-title":"Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine\u2013driven inflammation and fibrosis","volume":"8","author":"Vannella","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2023.115144_b0270","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI8204","article-title":"Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation","volume":"104","author":"Ray","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2023.115144_b0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/eji.201646450","article-title":"GATA-3-specific DNAzyme\u2014A novel approach for stratified asthma therapy","volume":"47","author":"Garn","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.03.029","article-title":"Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma","volume":"229","author":"Xie","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0285","doi-asserted-by":"crossref","first-page":"11192","DOI":"10.1021\/acsnano.0c07781","article-title":"A GATA3 targeting nucleic acid nanocapsule for in vivo gene regulation in asthma","volume":"15","author":"Gavitt","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115144_b0290","article-title":"The mixture of siRNAs targeted to IL-4 and IL-13 genes effectively reduces the airway hyperreactivity and allergic inflammation in a mouse model of asthma","volume":"103","author":"Shilovskiy","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2023.115144_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105966","article-title":"Proteomics: An advanced tool to unravel the role of alveolar macrophages in respiratory diseases","volume":"134","author":"Chiang","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.addr.2023.115144_b0300","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/mi.2012.74","article-title":"The alveolar macrophages in asthma: a double-edged sword","volume":"5","author":"Balhara","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MCP.0000000000000647","article-title":"The different faces of the macrophage in asthma","volume":"26","author":"van der Veen","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.addr.2023.115144_b0310","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1039\/C9NR06382J","article-title":"Targeted delivery of Chil3\/Chil4 siRNA to alveolar macrophages using ternary complexes composed of HMG and oligoarginine micelles","volume":"12","author":"Choi","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2023.115144_b0315","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2012.02.028","article-title":"The role of dendritic cells in asthma","volume":"129","author":"Gill","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0320","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.v25.i6.20","article-title":"The phenotype and function of lung dendritic cells","volume":"25","author":"Webb","year":"2005","journal-title":"Critical Reviews\u2122 in Immunology"},{"key":"10.1016\/j.addr.2023.115144_b0325","first-page":"299","article-title":"Dendritic cells in asthma: A target for novel therapeutics?","volume":"3","author":"van Rijt","year":"2006","journal-title":"Drug Discovery Today: Therapeutic Strategies"},{"key":"10.1016\/j.addr.2023.115144_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1436-4","article-title":"OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K\/AKT and P38 MAPK signaling pathway","volume":"16","author":"Huang","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.addr.2023.115144_b0335","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.omtn.2019.02.013","article-title":"Intratracheal administration of siRNA triggers mRNA silencing in the lung to modulate T cell immune response and lung inflammation","volume":"16","author":"Ng","year":"2019","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"10.1016\/j.addr.2023.115144_b0340","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1371\/journal.pmed.0040112","article-title":"Chronic obstructive pulmonary disease: a growing but neglected global epidemic","volume":"4","author":"Barnes","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.addr.2023.115144_b0345","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1183\/20734735.026410","article-title":"Similarities and differences in inflammatory mechanisms of asthma and COPD","volume":"7","author":"Barnes","year":"2011","journal-title":"Breathe"},{"key":"10.1016\/j.addr.2023.115144_b0350","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0355","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellularmechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2023.115144_b0360","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fimmu.2014.00435","article-title":"Role of alveolar macrophages in chronic obstructive pulmonary disease","volume":"5","author":"Vlahos","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coph.2021.07.001","article-title":"Editorial overview: Respiratory: Pulmonary pharmacology\u2013The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives","volume":"60","author":"Cazzola","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.addr.2023.115144_b0370","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2020.04.007","article-title":"Therapeutic RNA strategies for chronic obstructive pulmonary disease","volume":"41","author":"Mei","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.601155","article-title":"Optimizing the intracellular delivery of therapeutic anti-inflammatory tnf-\u03b1 sirna to activated macrophages using lipidoid-polymer hybrid nanoparticles","volume":"8","author":"Lokras","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2023.115144_b0380","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.18632\/oncotarget.6562","article-title":"Chronic NF-\u03baB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs","volume":"7","author":"Zaynagetdinov","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2023.115144_b0385","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.omtn.2018.05.027","article-title":"Ribosomal protein S3 gene silencing protects against cigarette smoke-induced acute lung injury","volume":"12","author":"Dong","year":"2018","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"10.1016\/j.addr.2023.115144_b0390","unstructured":"J. Van Straaten, W. Coers, J.A. Noordhoek, S. Huitema, J. Flipsen, H. Kauffman, W. Timens, D.S. Postma, Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema, Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc, 12 (1999) 697-705."},{"key":"10.1016\/j.addr.2023.115144_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-9-41","article-title":"Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease","volume":"9","author":"Merrilees","year":"2008","journal-title":"Respir. Res."},{"key":"10.1016\/j.addr.2023.115144_b0400","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1582-4934.2011.01492.x","article-title":"Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung","volume":"16","author":"Zhang","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2023.115144_b0405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/COPD.S116217","article-title":"Deposition of insoluble elastin by pulmonary fibroblasts from patients with COPD is increased by treatment with versican siRNA","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.addr.2023.115144_b0410","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/resp.12542","article-title":"Bronchial epithelial cells: the key effector cells in the pathogenesis of chronic obstructive pulmonary disease?","volume":"20","author":"Gao","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.addr.2023.115144_b0415","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123614","article-title":"Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene","volume":"3","author":"Wells","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.addr.2023.115144_b0420","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1183\/09031936.00121611","article-title":"Matrix metalloproteinases in COPD","volume":"39","author":"Churg","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2023.115144_b0425","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1440-1843.2011.01960.x","article-title":"EMMPRIN (CD147) regulation of MMP-9 in bronchial epithelial cells in COPD","volume":"16","author":"Jouneau","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.addr.2023.115144_b0430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jamp.2009.0802","article-title":"New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways","volume":"23","author":"Lai","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2023.115144_b0435","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000067462","article-title":"Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis","volume":"67","author":"Miravitlles","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.addr.2023.115144_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.05.041","article-title":"Natural inhibitors on airway mucin: Molecular insight into the therapeutic potential targeting MUC5AC expression and production","volume":"231","author":"Samsuzzaman","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2023.115144_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-019-0791-0","article-title":"CD147 increases mucus secretion induced by cigarette smoke in COPD","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.addr.2023.115144_b0450","doi-asserted-by":"crossref","first-page":"L334","DOI":"10.1152\/ajplung.00059.2016","article-title":"Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells","volume":"312","author":"Song","year":"2017","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.addr.2023.115144_b0455","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.48.1741","article-title":"Acute lung injury review","volume":"48","author":"Tsushima","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.addr.2023.115144_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.addr.2023.115144_b0465","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/jor1040024","article-title":"Role of Macrophage Polarization in Acute Respiratory Distress Syndrome, Journal of","volume":"1","author":"Mishra","year":"2021","journal-title":"Respiration"},{"key":"10.1016\/j.addr.2023.115144_b0470","volume":"8","author":"Chen","year":"2020","journal-title":"Antiplatelet Therapy for Acute Respiratory Distress Syndrome"},{"key":"10.1016\/j.addr.2023.115144_b0475","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/acs.biomac.7b00572","article-title":"Anti-inflammatory effect of anti-TNF-\u03b1 SiRNA cationic phosphorus dendrimer nanocomplexes administered intranasally in a murine acute lung injury model","volume":"18","author":"Bohr","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2023.115144_b0480","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.ymthe.2018.06.007","article-title":"Exosome-mediated small RNA delivery: a novel therapeutic approach for inflammatory lung responses","volume":"26","author":"Zhang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2023.115144_b0485","first-page":"3376","article-title":"Effect of TLR4\/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response","volume":"15","author":"Zhou","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2023.115144_b0490","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2022.10.020","article-title":"Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment","volume":"352","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0495","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2013.12.008","article-title":"Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury","volume":"175","author":"Oh","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0500","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/ACI.0b013e3280114eef","article-title":"Mucociliary clearance\u2013a critical upper airway host defense mechanism and methods of assessment","volume":"7","author":"Antunes","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0505","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijpharm.2017.07.022","article-title":"Tracing molecular and structural changes upon mucolysis with N-acetyl cysteine in human airway mucus","volume":"533","author":"Vukosavljevic","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0510","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/jcm6120112","article-title":"Airway mucus and asthma: the role of MUC5AC and MUC5B","volume":"6","author":"Bonser","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.addr.2023.115144_b0515","article-title":"Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties","volume":"114141","author":"Huck","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114141","article-title":"Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties","volume":"183","author":"Huck","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0525","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1172\/JCI73469","article-title":"Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure","volume":"124","author":"Henderson","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2023.115144_b0530","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1042\/BST20170402","article-title":"Mucins: the frontline defence of the lung","volume":"46","author":"Ridley","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2023.115144_b0535","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88198","article-title":"Microstructural alterations of sputum in cystic fibrosis lung disease","volume":"1","author":"Duncan","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.addr.2023.115144_b0540","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1021\/acsbiomaterials.0c01728","article-title":"Modeling airway dysfunction in asthma using synthetic mucus biomaterials","volume":"7","author":"Song","year":"2021","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.addr.2023.115144_b0545","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2008.09.010","article-title":"Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy","volume":"61","author":"Griesenbach","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0550","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2023.115144_b0555","doi-asserted-by":"crossref","unstructured":"P. Mastorakos, A.L. Da Silva, J. Chisholm, E. Song, W.K. Choi, M.P. Boyle, M.M. Morales, J. Hanes, J.S. Suk, Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy, Proceedings of the National Academy of Sciences. 112 (2015) pp8720-8725.","DOI":"10.1073\/pnas.1502281112"},{"key":"10.1016\/j.addr.2023.115144_b0560","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0565","doi-asserted-by":"crossref","unstructured":"B.C. Tang, M. Dawson, S.K. Lai, Y.-Y. Wang, J.S. Suk, M. Yang, P. Zeitlin, M.P. Boyle, J. Fu, J. Hanes, Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier, Proceedings of the National Academy of Sciences. 106 (2009) pp19268-19273.","DOI":"10.1073\/pnas.0905998106"},{"key":"10.1016\/j.addr.2023.115144_b0570","doi-asserted-by":"crossref","first-page":"2008960","DOI":"10.1002\/adfm.202008960","article-title":"Pro-peptide-reinforced, mucus-penetrating pulmonary siRNA delivery mitigates cytokine storm in pneumonia","volume":"31","author":"Yang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2023.115144_b0575","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpb.2017.12.017","article-title":"Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls","volume":"124","author":"Nafee","year":"2018","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.v"},{"key":"10.1016\/j.addr.2023.115144_b0580","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00011-018-1191-2","article-title":"A review of inflammatory mechanism in airway diseases","volume":"68","author":"Aghasafari","year":"2019","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.addr.2023.115144_b0585","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.09.008","article-title":"Bioresponsive drug delivery systems for the treatment of inflammatory diseases","volume":"327","author":"Dou","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0590","doi-asserted-by":"crossref","first-page":"5730395","DOI":"10.1155\/2018\/5730395","article-title":"Reactive oxygen species in chronic obstructive pulmonary disease","volume":"2018","author":"Boukhenouna","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.addr.2023.115144_b0595","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1378\/chest.124.4.1373","article-title":"Oxidative stress in expired breath condensate of patients with COPD","volume":"124","author":"Kostikas","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.addr.2023.115144_b0600","first-page":"187","article-title":"Redox role of ROS and inflammation in pulmonary diseases","volume":"I","author":"Zuo","year":"2021","journal-title":"Lung Inflammation in Health and Disease, Volume I"},{"key":"10.1016\/j.addr.2023.115144_b0605","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.actbio.2022.06.024","article-title":"ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment","volume":"148","author":"Muhammad","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2023.115144_b0610","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12951-022-01435-4","article-title":"ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2023.115144_b0615","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2018.04.015","article-title":"Photoinduced PEG deshielding from ROS-sensitive linkage-bridged block copolymer-based nanocarriers for on-demand drug delivery","volume":"170","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.115144_b0620","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/COPD.S2089","article-title":"Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease","volume":"3","author":"Owen","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.addr.2023.115144_b0625","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/15412555.2013.764403","article-title":"Neutrophil elastase-mediated lung disease","volume":"10","author":"Sandhaus","year":"2013","journal-title":"COPD: J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.addr.2023.115144_b0630","doi-asserted-by":"crossref","DOI":"10.1097\/00063198-200301000-00005","article-title":"Role of matrix metalloproteinases in asthma","volume":"9","author":"Kelly","year":"2003","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.addr.2023.115144_b0635","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2019.09.012","article-title":"In-vitro and in-vivo characterization of a multi-stage enzyme-responsive nanoparticle-in-microgel pulmonary drug delivery system","volume":"316","author":"Mej\u00edas","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0640","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/acs.biomac.6b00164","article-title":"Size-limited penetration of nanoparticles into porcine respiratory mucus after aerosol deposition","volume":"17","author":"Murgia","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2023.115144_b0645","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijpharm.2017.03.094","article-title":"PEGylated composite nanoparticles of PLGA and polyethylenimine for safe and efficient delivery of pDNA to lungs","volume":"524","author":"Kolte","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0650","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ejcdt.2014.07.017","article-title":"Asthma remodeling: The pathogenic role of matrix metalloproteinase-9","volume":"63","author":"Farhat","year":"2014","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"key":"10.1016\/j.addr.2023.115144_b0655","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.bbamem.2017.04.019","article-title":"Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications","volume":"1859","author":"Hidalgo","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.addr.2023.115144_b0660","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jconrel.2015.09.004","article-title":"Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy","volume":"220","author":"De Backer","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0665","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bbamem.2008.03.021","article-title":"Current perspectives in pulmonary surfactant \u2014 Inhibition, enhancement and evaluation","volume":"1778","author":"Zuo","year":"2008","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.addr.2023.115144_b0670","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMra022387","article-title":"Hydrophobic surfactant proteins in lung function and disease","volume":"347","author":"Whitsett","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2023.115144_b0675","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","article-title":"Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins","volume":"291","author":"Guagliardo","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0680","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.bbamem.2014.01.028","article-title":"Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy","volume":"1838","author":"Lopez-Rodriguez","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.addr.2023.115144_b0685","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41578-023-00552-2","article-title":"The protein corona from nanomedicine to environmental science","volume":"8","author":"Mahmoudi","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2023.115144_b0690","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1021\/nn4054683","article-title":"Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona","volume":"7","author":"Hu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115144_b0695","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acs.biomac.5b00108","article-title":"Protein corona of nanoparticles: Distinct proteins regulate the cellular uptake","volume":"16","author":"Ritz","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2023.115144_b0700","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/17435390.2016.1155672","article-title":"Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages","volume":"10","author":"Shaw","year":"2016","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.addr.2023.115144_b0705","doi-asserted-by":"crossref","first-page":"eaau0810","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant\u2013biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.115144_b0710","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2015.08.030","article-title":"Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophages","volume":"217","author":"De Backer","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0715","article-title":"Cellular uptake and retention of nanoparticles: Insights on particle properties and interaction with cellular components","volume":"25","author":"Augustine","year":"2020","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.addr.2023.115144_b0720","doi-asserted-by":"crossref","DOI":"10.3390\/nano11081963","article-title":"Size-dependent internalization efficiency of macrophages from adsorbed nanoparticle-based monolayer","author":"Petithory","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2023.115144_b0725","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1007\/s11095-015-1701-7","article-title":"Distribution and cellular uptake of PEGylated polymeric particles in the lung towards cell-specific targeted delivery","volume":"32","author":"Shen","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2023.115144_b0730","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2022.05.006","article-title":"Exploring the intrinsic micro\u2212\/nanoparticle size on their in vivo fate after lung delivery","volume":"347","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0735","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejpb.2014.12.001","article-title":"Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome","volume":"89","author":"Patel","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2023.115144_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112324","article-title":"Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs","volume":"128","author":"Shukla","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2023.115144_b0745","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2023.115144_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114173","article-title":"Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?","volume":"183","author":"Forest","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0755","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: Journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2023.115144_b0760","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1039\/C8SM00925B","article-title":"The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants","volume":"14","author":"Mousseau","year":"2018","journal-title":"Soft Matter"},{"key":"10.1016\/j.addr.2023.115144_b0765","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2015.03.015","article-title":"Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery system","volume":"206","author":"De Backer","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0770","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jbiosc.2021.08.009","article-title":"Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis","volume":"132","author":"Chae","year":"2021","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.addr.2023.115144_b0775","article-title":"In vivo biodistribution of respirable solid lipid nanoparticles surface-decorated with a mannose-based surfactant","volume":"10","author":"Truzzi","year":"2020","journal-title":"A Promising Tool for Pulmonary Tuberculosis Treatment?"},{"key":"10.1016\/j.addr.2023.115144_b0780","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s11095-010-0149-z","article-title":"Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages","volume":"27","author":"Yu","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2023.115144_b0785","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1164\/ajrccm\/148.3.689","article-title":"HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis","volume":"148","author":"Vignola","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2023.115144_b0790","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/mt.2008.38","article-title":"A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer","volume":"16","author":"Tagalakis","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2023.115144_b0795","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2019.05.021","article-title":"Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers","volume":"305","author":"Roki","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121586","article-title":"TLR7 agonist loaded airway epithelial targeting nanoparticles stimulate innate immunity and suppress viral replication in human bronchial epithelial cells","volume":"617","author":"Kan","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0805","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.actbio.2018.08.012","article-title":"Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy","volume":"78","author":"Merckx","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2023.115144_b0810","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.1021\/acsnano.0c04489","article-title":"Surfactant protein B promotes cytosolic SiRNA delivery by adopting a virus-like mechanism of action","volume":"15","author":"Guagliardo","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115144_b0815","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1203\/00006450-199604000-00025","article-title":"Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys","volume":"39","author":"Revak","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.addr.2023.115144_b0820","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/acs.molpharmaceut.7b00725","article-title":"From pulmonary surfactant, synthetic KL4 peptide as effective sirna delivery vector for pulmonary delivery","volume":"14","author":"Qiu","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0825","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/nat.2020.0855","article-title":"Modification of KL4 peptide revealed the importance of alpha-helical structure for efficient siRNA delivery","volume":"31","author":"Qiu","year":"2021","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2023.115144_b0830","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1021\/acs.molpharmaceut.0c01242","article-title":"Optimization of PEGylated KL4 peptide for siRNA delivery with improved pulmonary tolerance","volume":"18","author":"Qiu","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0835","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2021.08.021","article-title":"Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma","volume":"338","author":"Han","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0840","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2007.05.017","article-title":"Modulating leukocyte recruitment in inflammation","volume":"120","author":"Kelly","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115144_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110755","article-title":"Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation","volume":"188","author":"Wang","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2023.115144_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121418","article-title":"Lung cell membrane-coated nanoparticles capable of enhanced internalization and translocation in pulmonary epithelial cells","volume":"613","author":"Jakaria","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0855","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes\u2500nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics","volume":"16","author":"Tenchov","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115144_b0860","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41467-020-14344-7","article-title":"Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis","volume":"11","author":"Dinh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.115144_b0865","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41551-022-00902-5","article-title":"Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2023.115144_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2022.100002","article-title":"Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung","volume":"1","author":"Popowski","year":"2022","journal-title":"Extracellular Vesicle"},{"key":"10.1016\/j.addr.2023.115144_b0875","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jconrel.2022.03.039","article-title":"Can pulmonary RNA delivery improve our pandemic preparedness?","volume":"345","author":"Merkel","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115144_b0880","doi-asserted-by":"crossref","first-page":"1805116","DOI":"10.1002\/adma.201805116","article-title":"Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2023.115144_b0885","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1021\/acsnano.5b01181","article-title":"Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant","volume":"9","author":"Valle","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115144_b0890","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rppnen.2013.01.004","article-title":"Nanoparticles, nanotechnology and pulmonary nanotoxicology","volume":"19","author":"Ferreira","year":"2013","journal-title":"Revista Portuguesa De Pneumologia (english Edition)"},{"key":"10.1016\/j.addr.2023.115144_b0895","first-page":"1703","article-title":"Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges, nanomedicine: Nanotechnology","volume":"12","author":"Haque","year":"2016","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.addr.2023.115144_b0900","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/cts.12624","article-title":"Targeting RNA: A Transformative Therapeutic Strategy","volume":"12","author":"Yin","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.addr.2023.115144_b0905","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2019.05.019","article-title":"Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders","volume":"566","author":"Wu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115144_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106158","article-title":"Particle engineering in dry powders for inhalation","volume":"172","author":"Scherlie\u00df","year":"2022","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23004593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23004593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:47:42Z","timestamp":1759211262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X23004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":182,"alternative-id":["S0169409X23004593"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.115144","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano\u2013bio interactions","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.115144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115144"}}